Robust Biopharmaceutical Pipeline Offers New Hope for Patients

Washington, D.C. (January 17, 2013) —The biopharmaceutical pipeline is innovative and robust, with a high proportion of potential first-in-class medicines and therapies targeting diseases with limited treatment options, according to a new report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA).  

Medicines in Development: Older Americans

Innovation in the Biopharmaceutical Pipeline

Research in Your Backyard: Developing Cures, Creating Jobs - Pharmaceutical Clinical Trials in Wisconsin

Research in West Virginia

Research in Washington

Research in Virginia

Research in Oregon

Research in Ohio

Research in New York


Subscribe to RSS - Innovation